Saturday, July 11, 2026

pharma · Hypogonadism · Alzheimer's Disease

Chemical Works of

Chemical Works of is a pharma organization headquartered in EU. Primary therapeutic focus areas include Hypogonadism, Alzheimer's Disease. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent recor

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
2
Drugs
1
Patents
0
Clinical program

SK-PC-B70M

Phase 2 · small molecule · Alzheimer's Disease

SK-PC-B70M for Alzheimer's Disease is a Phase 2 program (small_molecule) at Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.) with 1 ClinicalTrials.gov record(s).

Internal code SMART_II_2006

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Phase
Phase 2
Modality
small_molecule
Indication
Alzheimer's Disease
Status
completed
Trials
1

Clinical trials